- Filed
- May 15, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2023 · May 15, 2023 | 34.51M sh |
| Shares Diluted | Q2 2023 · Mar 31, 2023 | 34.51M sh |
| Shares Diluted | Q2 2023 · Mar 31, 2023 | 34.51M sh |
| Shares Diluted | Q2 2023 · Mar 31, 2022 | 34.51M sh |
| Shares Diluted | Q2 2023 · Mar 31, 2022 | 34.51M sh |
| Capex | Q2 2023 · Mar 31, 2023 | $6.83K |
| Capex | Q2 2023 · Mar 31, 2022 | $1.76K |
| Operating Cash Flow | Q2 2023 · Mar 31, 2023 | −$341.46K |
| Operating Cash Flow | Q2 2023 · Mar 31, 2022 | $431.4K |
| Current Liabilities | Q2 2023 · Mar 31, 2023 | $505.45K |
| Current Liabilities | Q2 2023 · Sep 30, 2022 | $551.73K |
| Total Liabilities | Q2 2023 · Mar 31, 2023 | $846.5K |
| Total Liabilities | Q2 2023 · Sep 30, 2022 | $837.87K |
| Current Assets | Q2 2023 · Mar 31, 2023 | $3.61M |
| Current Assets | Q2 2023 · Sep 30, 2022 | $3.33M |
| Total Assets | Q2 2023 · Mar 31, 2023 | $3.65M |
| Total Assets | Q2 2023 · Sep 30, 2022 | $3.53M |
| Eps Diluted | Q2 2023 · Mar 31, 2023 | $0.00 |
| Eps Diluted | Q2 2023 · Mar 31, 2023 | $0.00 |
| Eps Diluted | Q2 2023 · Mar 31, 2022 | $0.00 |
| Eps Diluted | Q2 2023 · Mar 31, 2022 | $0.00 |
| Eps Basic | Q2 2023 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q2 2023 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q2 2023 · Mar 31, 2022 | $0.00 |
| Eps Basic | Q2 2023 · Mar 31, 2022 | $0.00 |
| Sga Expense | Q2 2023 · Mar 31, 2023 | $155.94K |
| Sga Expense | Q2 2023 · Mar 31, 2023 | $332.4K |
| Sga Expense restated | Q2 2023 · Mar 31, 2022 | $249.43K |
| Sga Expense restated | Q2 2023 · Mar 31, 2022 | $425.5K |
| Net Income | Q2 2023 · Mar 31, 2023 | $104.46K |
| Net Income | Q2 2023 · Dec 31, 2022 | −$13.66K |
| Net Income | Q2 2023 · Mar 31, 2022 | $69.25K |
| Net Income | Q2 2023 · Mar 31, 2022 | $115.68K |
| Net Income | Q2 2023 · Dec 31, 2021 | $46.44K |
| Operating Income | Q2 2023 · Mar 31, 2023 | $158.31K |
| Operating Income | Q2 2023 · Mar 31, 2023 | $202.47K |
| Operating Income | Q2 2023 · Mar 31, 2022 | $56.14K |
| Operating Income | Q2 2023 · Mar 31, 2022 | $118.35K |
| Gross Profit | Q2 2023 · Mar 31, 2023 | $711.82K |
| Gross Profit | Q2 2023 · Mar 31, 2023 | $1.33M |
| Gross Profit | Q2 2023 · Mar 31, 2022 | $676.88K |
| Gross Profit | Q2 2023 · Mar 31, 2022 | $1.21M |
| Cost Of Revenue | Q2 2023 · Mar 31, 2023 | $425.14K |
| Cost Of Revenue | Q2 2023 · Mar 31, 2023 | $845.73K |
| Cost Of Revenue | Q2 2023 · Mar 31, 2022 | $401.04K |
| Cost Of Revenue | Q2 2023 · Mar 31, 2022 | $724.7K |
| Revenue | Q2 2023 · Mar 31, 2023 | $1.14M |
| Revenue | Q2 2023 · Mar 31, 2023 | $2.18M |
| Revenue | Q2 2023 · Mar 31, 2022 | $1.08M |
| Revenue | Q2 2023 · Mar 31, 2022 | $1.94M |
| Stockholders Equity | Q2 2023 · Sep 30, 2022 | $2.69M |
| Stockholders Equity | Q2 2023 · Mar 31, 2022 | $2.14M |
| Stockholders Equity | Q2 2023 · Dec 31, 2021 | $2.07M |
| Stockholders Equity | Q2 2023 · Sep 30, 2021 | $2.02M |